July 22, 2025 - 20:40

With limited manufacturing capacity and few training scenarios, the United States is lagging behind its adversaries in drone technology. As global military dynamics shift, the importance of advanced drone capabilities has never been more pronounced. Countries like China and Russia have made significant strides in drone development, focusing on both combat and surveillance applications.
The U.S. military's reliance on existing technology, coupled with bureaucratic hurdles in procurement and innovation, has hindered its ability to rapidly advance drone capabilities. Additionally, the lack of comprehensive training scenarios for drone operators has left the U.S. at a disadvantage.
Experts warn that without a concerted effort to enhance manufacturing processes and invest in cutting-edge training programs, the U.S. risks falling further behind in a domain that is increasingly critical for modern warfare. As tensions rise globally, the need for a robust drone strategy has never been more urgent for national security.
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...